This inventor holds 2 USPTO granted patents. Top assignee: Washington University. Active years: 1995-2002.
Company Filing History:
Years Active: 1995-2002
Title: Minh D Kosfeld: Innovator in Thrombospondin Receptor Binding Peptides
Introduction
Minh D Kosfeld is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptides that interact with thrombospondin receptors. With a total of 2 patents, his work has implications for various medical applications.
Latest Patents
Kosfeld's latest patents focus on thrombospondin receptor binding peptides. These novel short peptides are designed to bind to the thrombospondin 1 receptor. The peptides preferably consist of 5-13 amino acid residues that share the tripeptide Val-Val-Met. The specific sequences disclosed include RFYVVMWKQVTQS (Seq ID No. 1) and fragments containing the minimal sequence RFYVVM (Seq ID No. 3), as well as FIRVVMYEGKK (Seq ID No. 4) and fragments with the minimal sequence IRVVM (Seq ID No. 5).
Career Highlights
Kosfeld is affiliated with Washington University, where he continues to advance his research in peptide technology. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
His notable coworker is William A Frazier, with whom he has collaborated on various research projects.
Conclusion
Minh D Kosfeld's innovative work in thrombospondin receptor binding peptides showcases his expertise and contributions to the field of biochemistry. His patents reflect a commitment to advancing medical science through innovative peptide research.